Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetic modeling to adapt fluoroquinolone dosage
2014-004193-41Phase 4Active
- Sponsor
- CHU Rennes
- Start
- Jun 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofloxacin and ofloxacin in bacterial disease (2 arms), sponsored by CHU Rennes. Started Jun 2015; status: active.
02
Drugs
ciprofloxacinofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2014-004193-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004193-41.